Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhengzhou Giant Biochemistry Group is a prominent Chinese biotechnology company specializing in the research, development, and large-scale production of plant growth regulators and agrochemicals. Founded in 1996 and headquartered in Zhengzhou, Henan Province, the group is recognized as one of the world's largest producers of gibberellic acid (GA3). Its product portfolio includes a wide range of biochemicals such as ethephon, paclobutrazol, and various amino acid-based fertilizers. The company serves both domestic and international markets, providing solutions for yield enhancement and pest management in agriculture. It operates several manufacturing bases and is a key high-tech enterprise in China's biochemical sector. The group's expertise in fermentation and chemical synthesis allows it to maintain a competitive edge in the global agro-biotech market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhengzhou Giant Biochemistry Group.